Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21

Genomics

Volumn 62, Issue 3, 1999, Pages 529-532

  Beatty, Barbara G ^a,b,g   Qi, Shirley ^c   Pienkowska, Malgorzata ^c   Herbrick, Jo Anne ^e   Scheidl, Teresa ^a   Zhang, Zong M ^a   Kola, Ismail ^f   Scherer, Stephen W ^e   Seth, Arun ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d Medical Research Council Group in Periodontal Physiology   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOLIPASE A2;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 9P; DOWN SYNDROME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENOME; HUMAN; LUNG CARCINOMA; MELANOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

MURINAE;

EID: 0033572357     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5999     Document Type: Article

References (16)

1. Chopra, A. K., Ribardo, D. A., Wood, T. G., Prusak, D. J., Xu, X.-J., and Peterson, J. W. (1999). Molecular characterization of cDNA for phospholipase A2-activating protein. Biochim. Biophys. Acta 1444: 125-130.
2. Clark, M. A., Ozgur, L. E., Conway, T. M., Dispoto, J., Crooke, S. T., and Bomalaski, J. S. (1991). Cloning of a phospholipase A2-activating protein. Proc. Natl. Acad. Sci. USA 88: 5418-5422.
3. Goddard, D. H., Bomalaski, J. S., Lipper, S., Shorr, R. G., and Clark, M. A. (1996). Phospholipase A2-mediated inflammation induces regression of malignant gliomas. Cancer Lett. 102: 1-6.
4. Hannon, G. J., and Beach, D. (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
5. Heng, H. H., Squire, J., and Tsui, L. C. (1992). High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA 89: 9509-9513.
6. Heng, H. H., and Tsui, L. C. (1994). FISH detection on DAPI-banded chromosomes. Methods Mol. Biol. 33: 35-49.
7. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55: 4525-4530.
8. Hudson, T. J., Stein, L. D., Gerety, S. S., Ma, J., Castle, A. B., Silva, J., Slonim, D. K., Baptista, R., Kruglyak, L., Xu, S. H., et al. (1995). An STS-based map of the human genome. Science 270: 1919-1920.
9. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. R., Johnson, B. E., and Skolnick, M. H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
10. Puig, S., Ruiz, A., Lazaro, C., Castel, T., Lynch, M., Palou, J., Vilalta, A., Weissenbach, J., Mascaro, J. M., and Estivill, X. (1995). Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57: 395-402.
11. Robinson, L., Panayiotakis, A., Papas, T. S., Kola, I., and Seth, A. (1997). ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. Proc. Natl. Acad. Sci. USA 94: 7170-7175.
12. Sorensen, P. H., Shimada, H., Liu, X. F., Lim, J. F., Thomas, G., and Triche, T. J. (1995). Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res. 55: 1385-1392.
13. Sumarsono, S. H., Wilson, T. J., Tymms, M. J., Venter, D. J., Corrick, C. M., Kola, R., Lahoud, M. H., Papas, T. S., Seth, A., and Kola, I. (1996). Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 379: 534-537.
14. Venanzoni, M. C., Robinson, L. R., Hodge, D. R., Kola, I., and Seth, A. (1996). ETS1 and ETS2 in p53 regulation: Spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Oncogene 12: 1199-1204.
15. Weaver-Feldhaus, J., Gruis, N. A., Neuhausen, S., Le Paslier, D., Stockert, E., Skolnick, M. H., and Kamb, A. (1994). Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA 91: 7563-7567.
16. Wiest, J. S., Franklin, W. A., Otstot, J. T., Forbey, K., Varella-Garcia, M., Rao, K., Drabkin, H., Gemmill, R., Ahrent, S., Sidransky, D., Saccomanno, G., Fountain, J. W., and Anderson, M. W. (1997). Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene. Cancer Res. 57: 1-6.